M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.37 USD 0.85% Market Closed
Market Cap: 117.3m USD
Have any thoughts about
MDxHealth SA?
Write Note

Wall Street
Price Targets

MDXH Price Targets Summary
MDxHealth SA

Wall Street analysts forecast MDXH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXH is 6.16 USD with a low forecast of 4.24 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.24 USD
79% Upside
Average
Price Target
6.16 USD
160% Upside
Highest
Price Target
7.35 USD
210% Upside
MDxHealth SA Competitors:
Price Targets
BVXP
Bioventix PLC
64% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
197% Upside
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
78% Upside
ATYR
aTyr Pharma Inc
464% Upside
DYAI
Dyadic International Inc
425% Upside
206650
EuBiologics Co Ltd
34% Upside
ALRN
Aileron Therapeutics Inc
477% Upside
IPSC
Century Therapeutics Inc
876% Upside

Revenue
Forecast

Revenue Estimate
MDxHealth SA

For the last 8 years the compound annual growth rate for MDxHealth SA's revenue is 19%. The projected CAGR for the next 4 years is 20%.

19%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
MDxHealth SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXH's stock price target?
Price Target
6.16 USD

According to Wall Street analysts, the average 1-year price target for MDXH is 6.16 USD with a low forecast of 4.24 USD and a high forecast of 7.35 USD.

What is MDxHealth SA's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for MDxHealth SA's revenue is 19%. The projected CAGR for the next 4 years is 20%.

Back to Top